Former Postdoctoral Research Associates

 

Dr. Rajeswari 

Mukherjee

email

Education:
M.S. Organic Chemistry (2005) and B.S. Chemistry (2003): University of Calcutta, Kolkata, West Bengal, India; Ph.D.Organic Chemistry (2015): Wake Forest University,Winston-Salem, NC, USA;  Current project: Scale-up of Lead Cathepsin L Inhibitors

 

 

 

Dr. Deboprosad Mondal

 

 

 

 

 

 

Song_HSJiangli Song, Ph.D.

Education: B.S. Chemistry and Biochemistry, August 2012
Ph.D. Organic Chemistry, Baylor University (2012)

Dissertation entitled: “Design and Synthesis of Non-peptidic Thiosemicarbazone Derivatives as Inhibitors of Cathepsins L and K.” Postdoctoral Associate, Baylor University (2007-2013)

 

 

Dr. Rajendra Tanpure

Education: B.S. Chemistry, R.Y.K. Science College, Nasik, India;
M.S. Organic Chemistry, IIT Mumbai, India;
Ph.D. Organic Chemistry, Baylor University (2003)

Postdoctoral Fellowship, Scripps Research Institute, La Jolla (2004-2005);
Postdoctoral Fellowship, UCLA (2005-2007);
Postdoctoral Fellowship, Baylor University (2007-2012)

KishoreDr. Kishore Kumar Gaddale Devanna

Education: B.S., M.S. Chemistry, Vivekananda College, Madras University, Chennai, India;
Ph.D. Synthetic Organic Chemistry, Indian Institute of Technology Madras (IITM), Chennai, India.

Postdoctoral Associate, UTMB, Galveston, TX (2005-2007);
Postdoctoral Associate, Baylor University (2007-2010)

Dr. Madhavi Sriram

 

Dr. Rajsekhar Guddneppanavar

Teacher-Scholar Postdoctoral Fellow, Department of Chemsitry, Wake Forest University

Dr. Ming Zhou

 

Dr. Vani Mocharla

 

Dr. Anjan Ghatak

 

Dr. Nandeo Choony

 

Former Graduate Students

Graham Carlson

email

Education:

B.S. Chemistry, Hope College, Holland, MI, 2014;

Ph.D. in Chemistry, 2021

 

 

 

 

 

 Jacob Ford

email

Education: B.S. Chemistry, University of Texas – Tyler, TX, 2013;

Ph.D. Chemistry, 2021

 

 

 

Casey Maguire

email

Education:

B.S. Biochemistry, St. Edward’s University, 2012

Ph.D. Chemistry, 2019

 

 

Haichan Niu

Ph.D. (Chemistry and Biochemistry),  December 15, 2018

Dissertation entitled:  “Efficient Synthetic Methodology for the Construction of Dihydronaphthalene and Benzosuberene Molecular Scaffolds and Structure Guided Design, Synthesis and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization”

Lauren Freeman

Education:

B.S. Chemistry, Baylor University, 2015

Graduated December 2021

 

 

 

 

 

 

Zhe Shi

Ph.D. (Chemistry and Biochemistry),  August 11, 2018

Dissertation entitled:  “Small-Molecule Inhibitors of Tubulin Polymerization as Vascular Disrupting Agents and Prodrugs Targeting Tumor-Associated Hypoxia”

 

 

 

Blake Winn

Ph.D. (Chemistry and Biochemistry), May 2017

Dissertation entitled:  “Synthesis, Characterization, and Biological Evaluation of Bioreductively Activatable Prodrug Conjugates (BAPCs) of Phenstatin, KGP18, OXi6196, Combretastatin A-1, and Combretastatin A-4”

 

 

 

Christine_HS

Christine Herdman

Ph.D. (Chemistry and Biochemistry), August, 2016

Dissertation entitled:  “Synthesis and Biological Evaluation of Potential Vascular Disrupting and Antimitotic Agents Utilizing Benzosuberene, Benzocyclooctene, and Indene Molecular Frameworks”

 

 

 

Erica_HS

Erica Parker

Education:
B.S. Chemistry, Texas A&M University-Commerce, 2009

Graduated December 2015

 

 

 

 

Eric_HS

Chen-Ming “Eric” Lin

Education:
B.S. Pharmaceutical Science, National Taiwan University, Taipei, Taiwan, 2005

Graduated December 2015

 

 

 

Laxman_HS

Laxman Devkota

Education:
M.S. Organic Chemistry, Tribhuvan University, Kathmandu, Nepal, 2005

Experience: Lecturer in Chemistry, Kathmandu University, Nepal, 2006-2009

Graduated December 2015

 

Matt_HS

Matt MacDonough, Ph.D.

Chemistry and Biochemistry, December 2013.

Dissertation entitled: “The Design, Synthesis, and Biological Evaluation of Indole-based Anticancer Agents.”

 

 

 

 

Song_HSJiangli Song, Ph.D.

Chemistry and Biochemistry, August 2012

Dissertation entitled: “Design and Synthesis of Non-peptidic Thiosemicarbazone Derivatives as Inhibitors of Cathepsins L and K.”

 

 

 

Clinton_HSClinton George, Ph.D.

Chemistry and Biochemistry, May 2012

Dissertation entitled: “Targeting the Tumor Microenvironment through the Design and Synthesis of Highly Cytotoxic Anticancer Agents.”

 

 

 

Lindsay_HSLindsay Jones, Ph.D.

Chemistry and Biochemistry, May 2012

Dissertation entitled: “Design and Synthesis of Functionalized Small-Molecule Inhibitors of Cathepsins L and K.”

 

 

 

 

Benson_HSBenson Nguyen, Ph.D.

Chemistry and Biochemistry, December, 2010

Dissertation entitled: “Design and Synthesis of Combretastatin A-1 Analogs, Small Molecule Vascular Disrupting Agents, and Bioreductive Triggers as Potential Therapeutic Agents for the Treatment of Cancer.”

OLYMPUS DIGITAL CAMERAGerardo Arturo Elguezabal-Torralba, Ph.D.

Chemistry and Biochemistry, August, 2010

Dissertation entitled: “Design and Synthesis of Potential Serotonin-Selective Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors for the Treatment of Depression.”

 

 

John J. Hall, Ph.D. (Chemistry and Biochemistry), May, 2008 (co-mentored by Dr. Mary Lynn Trawick)

Dissertation entitled: “Inhibitors of Tubulin, Nitric Oxide Synthase, and HIF-1 Alpha; Synthesis, Biological, and Biochemical Evaluation.”

Madhavi Sriram, Ph.D., December, 2007

Dissertation entitled: “Design, Synthesis, Biochemical, and Biological Evaluation of Benzocyclic and Enediyne Analogs of Combretastatins as Potential Tubulin Binding Ligands in the Treatment of Cancer.”

J. Freeland Ackley, M.S., December 2007

Thesis entitled: “Design, Synthesis and Evaluation of Di-nitrogen Derivatives of Combretastatin and Novel Cruzain Inhibiting Compounds for the Treatment of Chagas Disease”

Abhishek Dogra, M.S., December 2006

Thesis entitled: “Design and Synthesis of Dihydronaphthalene Vascular Disrupting Agents and Indolequinone-Based Bioreductives.”

M. Graciela Miranda, Ph.D., August, 2006

Dissertation entitled: “Design, Synthesis and Biological Evaluation of Novel Serotonin Reuptake Inhibitors and Novel Derivatives of a Nitrogen-Containing Combretastatin Analog.”

Rogelio Siles, Ph.D., December, 2005

Dissertation entitled: “Design, Synthesis and Biological Evaluation of New Anti-Cancer Nitrogen-Containing Combretastatins and Novel Cysteine Protease Inhibitors for the Treatment of Chagas Disease.”

Phyllis Arthasery, Ph.D., December, 2005

Dissertation entitled: “Discovery and Development of Unique Small Molecule Chromene Based Ligands and Combretastatin Analogs as Potential Second Generation Vascular Disrupting Agents Towards Cancer Chemotherapy.”

Hani Wehbe, Ph.D. (Institute of Biomedical Studies), August 2005(co-mentored by Dr. Christopher Kearney)

Dissertation entitled: “Towards Enhanced Cancer Chemotherapy: Studies on Drug Design, Synergy, and Drug Target Expression and Resistance with the Combretastatins and Other Chemotherapeutics.”

Mallinath B. Hadimani, Ph.D., December 2004

Dissertation entitled: “Studies Toward the Discovery of New Classes of Privileged Molecules as Colchicine-Site Binding Ligands for Tubulin: Structure-Based Design, Synthesis, and Bioactivity of Small Ligands Targeted at Tumor Vasculature.”

Christopher J. Jelinek, M.S., December 2004

Thesis entitled: “Discovery and Development of Dihydronaphthalene-Based Vascular Targeting Agents and Combretastatin-Related Analogs.”

Rajendra Prakash Tanpure, Ph.D., December, 2003

Dissertation entitled: “New Synthetic Methodology for the Stereoselective Preparation of Functionalized Conjugated Dienes from Alkynyl Oxirane Precursors: Synthesis and Biological Evaluation of Functionalized Triarylalkenes as Tubulin Binding Agents.”

Raymond J. Kessler, M.S., December, 2002

Thesis entitled: “Synthesis and Evaluation of New Inhibitors of Tubulin Polymerization and Their Corresponding Prodrugs as Potential Vascular Targeting Agents.”

Anupama Ramesh Shirali, Ph.D., August, 2002

Dissertation entitled: “Inhibitors of Tubulin Assembly: Designed Ligands Featuring Benzo[b]thiophene, Dihydronaphthalene and Aroylchromene Molecular Core Structures.”

David A. Walsh, M.S., August, 2002

Thesis entitled: “Synthesis and Evaluation of Conjugated One-Ynes (COYs) as a Novel Class of Anti-Cancer Drugs and ?-Turn Peptidomimetics as Viable Substitutes for the Alkene Bridge in Combretastatin A-4.”

James M. Dorsey, M.S., December, 2001

Thesis entitled: “Synthesis of Serotonin-Selective Reuptake Inhibitors With Novel Side Chains: Designing a Serotonin Reuptake Inhibitor with an Improved Adverse Reaction Profile.”

Heather O’Dell, M.A. (Biology, non-thesis), August, 2001

Successfully defended the oral research presentation portion of her MA degree in Biology on June 21, 2001 through a talk entitled: “The Biological Evaluation of Potential Vascular Targeting Agents.” Heather carried out a portion of her research in Dr. Kevin G. Pinney’s laboratory and then completed a six month internship in Professor Klaus Edvardsen’s laboratory in Lund, Sweden working in the area of tumor immunology.

Zhi Chen, M.S., December, 2000

Thesis entitled: “Synthesis of Tubulin Binding Ligands Incorporating Dihydronaphthalene, Indene, and Benzo[b]thiophene Molecular Frameworks and Preparation of Their Corresponding Phosphorous Containing Prodrugs as Tumor Specific Vascular Targeting Agents.”

Vani P. Mocharla, Ph.D., December, 1999

Dissertation entitled: “Design, Synthesis, and Biological Evaluation of Diverse Small Molecular Frameworks As Tubulin Binding Ligands.”

Maria del Pilar Mejia, Ph.D., May, 1999

Dissertation entitled: “Synthesis and Biological Evaluation of Novel Photoaffinity Labeling Reagents and Nitrogen Containing Compounds Modeled After Combretastatin A-4.”

Feng Wang, M.S., May, 1999

Thesis entitled: “Stereoselective Synthesis of Conjugated Diene Systems and Design of New Tubulin Polymerization Inhibitors as Antimitotic Agents.”

Amanda Crippen-Harkrider, M.S. December, 1998

Thesis entitled: “Designed Inhibitors of Tubulin Polymerization: Tamoxifen-Based Analogs.” (name listed as Amanda R. Harkrider on actual thesis).